RespireRx Pharmaceuticals Inc (RSPI): FWIW: I emailed the company today and...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

RespireRx Pharmaceuticals Inc (RSPI)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	88
Posts	7770
Boards Moderated	0
Alias Born	02/28/2004

Re: None

Friday, 11/30/2018 2:56:09 PM

Friday, November 30, 2018 2:56:09 PM

FWIW:

I emailed the company today and received an email within 10 minutes from Jeff Margolis. Of course, he could not tell me anything that is not public information, but he said that RSPI is alive and well, and he requested that I review the recent 10-Q, which I did.

His name and address at the bottom of the email was:

Jeff Eliot Margolis
Senior Vice President, Secretary, Treasurer, Chief Financial Officer & Member of the Board of Directors
RespireRx Pharmaceuticals Inc.
PO Box 1167
Bridgehampton, NY 11932-1167
(direct) 917-834-7206
(email) jmargolis@respirerx.com
(skype name) unluckyfisherman
(eFax) 415-887-7814

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM

More RSPI News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow